Analyst IMS Investment Management Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,894
| Closed | -$737K | – | 125 |
|
|
2025
Q2 | $737K | Hold |
1,894
| – | – | 0.03% | 100 |
|
|
2025
Q1 | $824K | Hold |
1,894
| – | – | 0.03% | 93 |
|
|
2024
Q4 | $699K | Hold |
1,894
| – | – | 0.03% | 96 |
|
|
2024
Q3 | $985K | Hold |
1,894
| – | – | 0.04% | 80 |
|
|
2024
Q2 | $1.03M | Hold |
1,894
| – | – | 0.04% | 70 |
|
|
2024
Q1 | $982K | Hold |
1,894
| – | – | 0.04% | 68 |
|
|
2023
Q4 | $893K | Hold |
1,894
| – | – | 0.05% | 67 |
|
|
2023
Q3 | $847K | Hold |
1,894
| – | – | 0.05% | 61 |
|
|
2023
Q2 | $834K | Hold |
1,894
| – | – | 0.06% | 60 |
|
|
2023
Q1 | $869K | Sell |
1,894
-81
| -4% | -$38.5K | 0.07% | 59 |
|
|
2022
Q4 | $1.01M | Sell |
1,975
-420
| -18% | -$213K | 0.09% | 58 |
|
|
2022
Q3 | $1.09M | Sell |
2,395
-95
| -4% | -$45.5K | 0.11% | 51 |
|
|
2022
Q2 | $1.2M | Sell |
2,490
-330
| -12% | -$163K | 0.11% | 53 |
|
|
2022
Q1 | $1.39M | Sell |
2,820
-1,110
| -28% | -$507K | 0.12% | 56 |
|
|
2021
Q4 | $1.84M | Sell |
3,930
-120
| -3% | -$50.5K | 0.17% | 52 |
|
|
2021
Q3 | $1.51M | Hold |
4,050
| – | – | 0.19% | 56 |
|
|
2021
Q2 | $1.55M | Sell |
4,050
-1,453
| -26% | -$555K | 0.19% | 56 |
|
|
2021
Q1 | $1.98M | Buy |
5,503
+1,251
| +29% | +$402K | 0.26% | 43 |
|
|
2020
Q4 | $1.36M | Sell |
4,252
-1,423
| -25% | -$437K | 0.23% | 49 |
|
|
2020
Q3 | $1.52M | Buy |
5,675
+19
| +0.3% | +$5.11K | 0.31% | 35 |
|
|
2020
Q2 | $1.49M | Sell |
5,656
-576
| -9% | -$154K | 0.35% | 35 |
|
|
2020
Q1 | $1.42M | Sell |
6,232
-382
| -6% | -$104K | 0.45% | 29 |
|
|
2019
Q4 | $2M | Buy |
6,614
+112
| +2% | +$30.8K | 0.54% | 31 |
|
|
2019
Q3 | $1.55M | Buy |
6,502
+1,324
| +26% | +$363K | 0.46% | 34 |
|
|
2019
Q2 | $1.46M | Buy |
5,178
+180
| +4% | +$49.2K | 0.44% | 42 |
|
|
2019
Q1 | $1.43M | Sell |
4,998
-5,022
| -50% | -$1.45M | 0.44% | 41 |
|
|
2018
Q4 | $2.63K | Buy |
10,020
+4,656
| +87% | +$1.28M | 0.42% | 28 |
|
|
2018
Q3 | $1.45K | Sell |
5,364
-252
| -4% | -$65.4K | 0.23% | 41 |
|
|
2018
Q2 | $1.34M | Buy |
5,616
+42
| +0.8% | +$9.73K | 0.41% | 43 |
|
|
2018
Q1 | $1.23M | Sell |
5,574
-214
| -4% | -$50.3K | 0.39% | 51 |
|
|
2017
Q4 | $1.3M | Sell |
5,788
-269
| -4% | -$57.3K | 0.4% | 49 |
|
|
2017
Q3 | $1.15M | Sell |
6,057
-55
| -0.9% | -$10.5K | 0.38% | 54 |
|
|
2017
Q2 | $1.15M | Sell |
6,112
-195
| -3% | -$35K | 0.41% | 55 |
|
|
2017
Q1 | $1.05M | Sell |
6,307
-328
| -5% | -$52.2K | 0.41% | 55 |
|
|
2016
Q4 | $954K | Sell |
6,635
-250
| -4% | -$33.5K | 0.42% | 56 |
|
|
2016
Q3 | $863K | Buy |
6,885
+3,390
| +97% | +$438K | 0.37% | 57 |
|
|
2016
Q2 | $459K | Buy |
+3,495
| New | +$478K | 0.19% | 73 |
|
Other funds holding ELV
Analyst IMS Investment Management Services's ELV Position: Q3 2025 in Review
Analyst IMS Investment Management Services sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,894 shares — an estimated $737K sold.
Analyst IMS Investment Management Services first reported a position in ELV in Q2 2016 and held it in 37 quarters. The position peaked at $2M in Q4 2019. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Analyst IMS Investment Management Services reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Analyst IMS Investment Management Services sold 1,894 Elevance Health shares in Q3 2025, an estimated $737K.
- Analyst IMS Investment Management Services first reported a position in Elevance Health in Q2 2016 and held it in 37 quarters.
- Analyst IMS Investment Management Services's Elevance Health position peaked at $2M in Q4 2019.
- 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Analyst IMS Investment Management Services's 13F filing for Q3 2025, filed 20 Oct 2025.